Irreversible inactivation of interleukin 2 in a pump-based delivery environment.

AUTOR(ES)

Tzannis, S T

RESUMO

The physical stability of pharmaceutical proteins in delivery environments is a critical determinant of biological potency and treatment efficacy, and yet it is often taken for granted. We studied both the bioactivity and physical stability of interleukin 2 upon delivery via continuous infusion. We found that the biological activity of the delivered protein was dramatically reduced by approximately 90% after a 24-hr infusion program. Only a portion of these losses could be attributed to direct protein deposition on the delivery surfaces. Analysis of delivered protein by size exclusion chromatography gave no indication of insulin-like, surface-induced aggregation phenomena. Examination of the secondary and tertiary structure of both adsorbed and delivered protein via Fourier-transform infrared spectroscopy, circular dichroism, and fluorescence spectroscopy indicated that transient surface association of interleukin 2 with the catheter tubing resulted in profound, irreversible structural changes that were responsible for the majority of the biological activity losses.

Documentos Relacionados

• Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin
• Bacterial survival in a dilute environment.
• Monitoring of lead in the environment.
• Identity-based cryptography environment.
• Normative models and healthcare planning: network-based simulations within a geographic information system environment.